Medicine

Corrigendum to "Recurrent Transcriptional Responses in AML and MDS patients Treated with Decitabine" Experimental Hematology. 2022;111:50-65.

P. Upadhyay, Jeremy T. Beales, N. Shah, Agata Gruszczynska, Christopher A Miller, A. Petti, S. M. Ramakrishnan, Daniel C. Link, T. Ley, J. Welch

2026.6.1EXPERIMENTAL HEMATOLOGY

DOI: 10.1016/j.exphem.2026.105407

Abstract

Abstract is not available.

Citation format

UPADHYAY, P., et al. Corrigendum to "recurrent transcriptional responses in AML and MDS patients treated with decitabine" experimental hematology. 2022;111:50-65. EXPERIMENTAL HEMATOLOGY, 2026, 158: 105407.